Management of comorbidities in older patients with cystic fibrosis
- 1 April 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 1 (2), 164-174
- https://doi.org/10.1016/s2213-2600(13)70025-0
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Risk Factors for Chronic Kidney Disease in Adults with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Cross-Sectional and Longitudinal Comparisons of the Predominant Fecal Microbiota Compositions of a Group of Pediatric Patients with Cystic Fibrosis and Their Healthy SiblingsApplied and Environmental Microbiology, 2011
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationThe New England Journal of Medicine, 2011
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutationThe New England Journal of Medicine, 2010
- Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasisMucosal Immunology, 2010
- Survey of acute renal failure in patients with cystic fibrosis in the UKThorax, 2007
- Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human boneThorax, 2007
- Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantationThorax, 2006
- Predicting the future burden of cancerNature Reviews Cancer, 2005